GlassScriptPhysician profile
Gary S Schwartz
NPI 1336464593
$756,438.05
in general payments reported to CMS, 2019-2025
35 companies · $146K in 2025
The $146K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,726 · 2020: $58K · 2021: $125K · 2022: $121K · 2023: $177K · 2024: $124K · 2025: $146K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $314K · Honoraria: $90K · Travel and Lodging: $35K · Food and Beverage: $7,754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $314,143.55 |
| Honoraria | $89,775.00 |
| Travel and Lodging | $35,439.56 |
| Food and Beverage | $7,754.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $740,145.90 | 2019-2025 | Iovera, Exparel, Zilretta |
| Octapharma USA, INC. | $5,385.25 | 2025 | Fibryga & Balfaxar |
| Vertex Pharmaceuticals Incorporated | $5,042.30 | 2024-2025 | |
| Abbott Laboratories | $2,043.85 | 2019-2020 | |
| Vertos Medical, INC. | $957.36 | 2019-2021 | |
| Becton, Dickinson and Company | $450.00 | 2024 | Hemosphere |
| Nevro Corp. | $336.48 | 2019-2022 | |
| Medtronic USA, INC. | $312.07 | 2019-2020 | |
| Boston Scientific Corporation | $238.48 | 2020-2022 | |
| Nuvasive, INC. | $176.06 | 2019 | |
| Fidia Pharma USA INC. | $170.30 | 2023 | Triluron, Hymovis |
| Spr Therapeutics, INC | $141.24 | 2025 | Sprint Pns System |
| Brixton Biosciences, INC. | $138.06 | 2025 | Neural Ice |
| Assertio Therapeutics, INC. | $115.23 | 2019 | |
| Relievant Medsystems, INC. | $81.71 | 2023 | Intracept |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $73.94 | 2024 | |
| Baudax Bio INC. | $64.13 | 2021 | |
| Horizon Therapeutics Plc | $64.04 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $48.69 | 2021-2022 | |
| Bioventus LLC | $47.22 | 2022 | |
| Si-Bone, INC. | $46.23 | 2025 | |
| Curonix LLC | $45.09 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.36 | 2019 | |
| Biodelivery Sciences International, INC. | $34.10 | 2019 | |
| Stimwave Technologies Incorporated | $32.93 | 2020 | |
| Pfizer INC. | $29.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $28.68 | 2019 | |
| Depuy Synthes Sales INC. | $28.42 | 2023 | Orthovisc |
| Almatica Pharma LLC | $25.25 | 2023 | Gralise |
| Collegium Pharmaceutical, INC. | $22.38 | 2024 | Xtampza |
| Nalu Medical, INC. | $17.37 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $16.42 | 2023 | Caldolor |
| Novartis Pharmaceuticals Corporation | $15.63 | 2019 | |
| Merck Sharp & Dohme LLC | $14.25 | 2019 | |
| Foundation Fusion Solutions, LLC | $12.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.